Recent Events & Catalysts
Arrowhead Pharmaceuticals (ARWR) — real, dated facts. Not a claim about what caused any single day's price move.
News
JP Morgan Maintains Overweight on Arrowhead Pharma, Raises Price Target to $95
Benzinga · today
Arrowhead gains EU authorisation for Redemplo in evolving FCS market
Yahoo · 3d ago
Here Are Tuesday’s Best Wall Street Analyst Research Calls: Apple, Bloom Energy, Circle Internet Group, First Solar, Halliburton, IBM, Intuit, Newmont, SK hynix, and More
Yahoo · 3d ago
This Arrowhead Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Benzinga · 3d ago
Stifel Initiates Coverage On Arrowhead Pharma with Buy Rating, Announces Price Target of $98
Benzinga · 3d ago
Can Biogen Convince Skeptics That Cutting a Rogue Protein Slows Alzheimer’s?
Yahoo · 4d ago
Ionis Pharmaceuticals Drops Another 9% as Bad News Piles Up
Yahoo · 7d ago
The Long Climb Back For Ionis Stock
Yahoo · 7d ago
SEC Filings (90 days)
Departure/appointment of directors or officers, Financial statements and exhibits
Filed 2026-06-16 · 31d ago
Results of operations (earnings release), Financial statements and exhibits
Filed 2026-05-07 · 71d ago · Material
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.